Most Recent

image: From Toxins to Therapeutics

From Toxins to Therapeutics

By | March 19, 2013

Researchers are finding new drugs for chronic pain and autoimmune diseases by modifying animal venom-derived molecules that target the nervous and immune systems.

1 Comment

image: Anthrax Vax Test OK for Kids

Anthrax Vax Test OK for Kids

By | March 19, 2013

A presidential bioethics commission lays out the framework for testing the anthrax vaccine in children.

0 Comments

image: Opinion: Genomics in the Clinic

Opinion: Genomics in the Clinic

By | March 18, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

0 Comments

image: Week in Review

Week in Review

By | March 15, 2013

Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research

0 Comments

image: Novel Virus Entry Portal Found

Novel Virus Entry Portal Found

By | March 13, 2013

Researchers identify the target protein of a recently discovered human coronavirus, shedding light on infection and possible interspecies spread.

1 Comment

image: Opinion:  Unconventional Standards

Opinion: Unconventional Standards

By | March 13, 2013

Tailoring ethical oversight to participant-led research

2 Comments

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

image: Antibody-Dependent Enhanced (ADE) Immunity

Antibody-Dependent Enhanced (ADE) Immunity

By | March 2, 2013

The method to the dengue virus's maddening infectiousness.

0 Comments

image: Networking Medicine

Networking Medicine

By | March 2, 2013

Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.

0 Comments

image: Antibiotic Bouncer

Antibiotic Bouncer

By | March 1, 2013

Contrary to previous assumptions that macrolide antibiotics completely block the exit tunnel of ribosomes, new evidence shows that some peptides are allowed to pass.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. Genetic Analysis Reveals the Evolutionary History of Dogs
  4. March for Science: Dispatches from Washington, DC
AAAS